The Centers For Disease Control and the World Health Organization have confirmed that a superbug of antibiotic resistant gonorrhea may be coming to your town. Researchers recently published results of a study involving the treatment of 133 confirmed cases of gonorrhea and concluded that 9 were "untreatable" after the typical course of the only treatment known to work.
The article regarding the cephalosporin resistant STD was published on January 9, 2013 in the Journal of the American Medical Association. The study, led by Vanessa Allen of Ontario's Public Health Department, found that the drug resistant super strain has already been detected in Japan, Austria, France, Norway, and the United Kingdom before it made its way to North America. Of the "super strain," Director of the CDC's sexually transmitted disease prevention program Gail Bolan offered in the Journal: "Our results aren't generalizable to the overall population because they all came from one clinic. But basically, the problem appears worse than we originally thought."
Many public health officials have expect this "super bug" and other organisms have rapidly and increasingly evolved as antibiotic resistant. This "gonorrhea super strain" has the potential to be widespread within the next five years, as the "threat of untreatable gonorrhea is emerging rapidly" per Bolan. They find the results of the study alarming and suggest people take appropriate precautions (including the use of condoms) before engaging in risky behavior. Some clinicians recommend ceftriaxone injections and a follow up with azithromycin or doxycycline as treatment for this super strain until an alternative option is discovered.